Cellares — Startup Profile

Automated manufacturing for cell therapies

HQ: South San Francisco, CA | Founded: 2019 | Employees: Not publicly disclosed | Stage: Venture-backed growth company | Website: https://www.cellares.com

About

Cellares develops integrated, automated technologies and facilities for cell-based treatment manufacturing, aiming to make personalized and engineered cell treatments more scalable.

The Take

Cellares targets a manufacturing bottleneck that can limit otherwise promising cell therdeveloper toolses. Automation and standardized facilities may improve cost and throughput, but validation, manufacturing quality, customer adoption, and clinical supply requirements make execution demanding.

Key Metrics

• Founded: 2019
• Founder: Fabian Gerlinghaus
• Latest signal: Cellares raises $257M Series D
• Products: 3

Funding Rounds

• Round: $257M (2026-01) — BlackRock and Eclipse
• Round: $255M (2023-08) — Not fully disclosed

Key People

• Fabian Gerlinghaus

Key Competitors

• Incumbent platforms —
• Specialist startups —

Timeline Highlights

• 2023-08: Series C
• 2026-01: Series D
• 2019: Founded

Recent News

• Cellares raises $257M Series D (2026-01-28)

Similar Startups

• Aether Biomachines — Designing industrial proteins with computers and biology.
• Enveda Biosciences — Finding medicines in the chemistry of nature.
• Chai Discovery — The computer-aided design suite for molecules
• Converge Bio — Generative AI for drug discovery and development
• NewLimit — Reprogramming cells to treat age-related disease

Browse: Home | Blog | About | All Startups A-Z | View full profile on StartupWiki